Anti Cancer Medicines
Showing 1–16 of 52 results
-
AVASTIN (bevacizumab) Solution for intravenous infusion. Initial U.S. Approval: 2004
Read more -
Bevacizumab Injection. Initial U.S. Approval: 2004
Read more -
BYNFEZIA PEN (octreotide acetate) injection, for subcutaneous useInitial U.S. Approval: 1988
Read more -
ELZONRIS (tagraxofusp-erzs) injection, for intravenous use. Initial U.S. Approval: 2018
Read more -
ENTADFI (finasteride and tadalafil) capsules
Read more -
ERLEADA (apalutamide) tablets, for oral use. Initial U.S. Approval – 2018
Read more -
ESBRIET (pirfenidone) capsules and film-coated tablets, for oral use Initial U.S. Approval: 2014
Read more -
EXKIVITY (mobocertinib) capsules
Read more -
fam-trastuzumab deruxtecan-nxki for injection, for intravenous use Initial U.S. Approval: 2019
Read more -
FOTIVDA (tivozanib) capsules
Read more -
INGREZZA (valbenazine) capsules, for oral use. Initial U.S. Approval: 2017
Read more -
INREBIC (fedratinib) capsules, for oral use. Initial U.S. Approval: 2019
Read more -
IXEMPRA Kit (ixabepilone) for Injection, for intravenous infusion only Initial U.S. Approval: 2007
Read more -
KADCYLA (ado-trastuzumab emtansine) for injection, for intravenous use. Initial U.S. Approval: 2013
Read more -
KEYTRUDA (pembrolizumab) injection, for intravenous use Initial U.S. Approval: 2014
Read more -
KORLYM (mifepristone) 300 mg Tablets Initial U.S. Approval 2000
Read more